-
My Account
In App
My Account
BSE Live
Dec 26, 16:01Prev. Close
5563.80
Open Price
5563.80
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 26, 15:56Prev. Close
5566.00
Open Price
5539.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
5535.00 (39)
| Cash Flow of Alkem Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 1,259.79 | 954.66 | 925.98 | 964.63 | 928.41 | |
| Net CashFlow From Operating Activities | 585.08 | 779.65 | 276.18 | 471.14 | 725.83 | |
| Net Cash Used In Investing Activities | -741.35 | -316.39 | -367.37 | -285.93 | 202.27 | |
| Net Cash Used From Financing Activities | 79.15 | -378.94 | 84.56 | -137.88 | -927.27 | |
| Foreign Exchange Gains / Losses | 4.01 | -1.98 | 6.71 | -7.73 | 2.47 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -73.11 | 82.34 | 0.08 | 39.60 | 3.30 | |
| Cash And Cash Equivalents Begin of Year | 249.05 | 166.71 | 166.63 | 127.03 | 123.75 | |
| Cash And Cash Equivalents End Of Year | 175.94 | 249.05 | 166.71 | 166.63 | 127.05 |
04.12.2025
Alkem Lab Consolidated September 2025 Net Sales at Rs 4,000.99 crore, up 17.17% Y-o-Y
24.11.2025
Alkem Lab Standalone September 2025 Net Sales at Rs 2,542.03 crore, down 11.49% Y-o-Y
10.09.2025
Alkem Lab Standalone June 2025 Net Sales at Rs 2,372.17 crore, down 5.12% Y-o-Y
12.08.2025
Q1 Results impact: Alkem Labs, PN Gadgil shares rally up to 10% on strong earnings, Granules up 4%
12.07.2023
Alkem Laboratories Q1 PAT seen up 135.1% YoY to Rs 299.7 cr: Nirmal Bang
17.10.2018
Alkem Labs Q2 PAT may dip 30.2% YoY to Rs. 220 cr: HDFC Securities
20.04.2018
Alkem Labs Q4 PAT may dip 1.5% YoY to Rs. 130 cr: HDFC Securities
12.04.2018
Pharma Q4 earnings preview: Tough quarter; US pricing pressure, domestic sales recovery hold key
